These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29212038)

  • 1. Co-chaperone BAG2 Determines the Pro-oncogenic Role of Cathepsin B in Triple-Negative Breast Cancer Cells.
    Yang KM; Bae E; Ahn SG; Pang K; Park Y; Park J; Lee J; Ooshima A; Park B; Kim J; Jung Y; Takahashi S; Jeong J; Park SH; Kim SJ
    Cell Rep; 2017 Dec; 21(10):2952-2964. PubMed ID: 29212038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program.
    Luan H; Mohapatra B; Bielecki TA; Mushtaq I; Mirza S; Jennings TA; Clubb RJ; An W; Ahmed D; El-Ansari R; Storck MD; Mishra NK; Guda C; Sheinin YM; Meza JL; Raja S; Rakha EA; Band V; Band H
    Cancer Res; 2018 May; 78(10):2524-2535. PubMed ID: 29510992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAG2 drives chemoresistance of breast cancer by exacerbating mutant p53 aggregate.
    Huang X; Shi D; Zou X; Wu X; Huang S; Kong L; Yang M; Xiao Y; Chen B; Chen X; Ouyang Y; Song L; Jian Y; Lin C
    Theranostics; 2023; 13(1):339-354. PubMed ID: 36593950
    [No Abstract]   [Full Text] [Related]  

  • 4. Up-regulation of cathepsin S expression by HSP90 and 5-HT
    Gautam J; Bae YK; Kim JA
    Breast Cancer Res Treat; 2017 Jan; 161(1):29-40. PubMed ID: 27796714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells.
    Krishnan SR; Nair BC; Sareddy GR; Roy SS; Natarajan M; Suzuki T; Peng Y; Raj G; Vadlamudi RK
    Breast Cancer Res Treat; 2015 Apr; 150(3):487-99. PubMed ID: 25788226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation.
    Lee YR; Kim KM; Jeon BH; Choi S
    Oncotarget; 2015 Sep; 6(27):23383-98. PubMed ID: 26125438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface.
    Nelson ER; Li S; Kennedy M; Payne S; Kilibarda K; Groth J; Bowie M; Parilla-Castellar E; de Ridder G; Marcom PK; Lyes M; Peterson BL; Cook M; Pizzo SV; McDonnell DP; Bachelder RE
    Oncotarget; 2016 Dec; 7(51):84030-84042. PubMed ID: 27768598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.
    Wu J; Sun Z; Sun H; Li Y
    Mol Med Rep; 2018 Jan; 17(1):562-570. PubMed ID: 29115608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2-associated athanogene 2 prevents the neurotoxicity of MPP+ via interaction with DJ-1.
    Song Z; Xu S; Song B; Zhang Q
    J Mol Neurosci; 2015 Mar; 55(3):798-802. PubMed ID: 25600833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells.
    de Paula CA; Santiago FE; de Oliveira AS; Oliveira FA; Almeida MC; Carrettiero DC
    Cell Mol Neurobiol; 2016 May; 36(4):593-602. PubMed ID: 26208804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAG2 structure, function and involvement in disease.
    Qin L; Guo J; Zheng Q; Zhang H
    Cell Mol Biol Lett; 2016; 21():18. PubMed ID: 28536620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression.
    Parvani JG; Davuluri G; Wendt MK; Espinosa C; Tian M; Danielpour D; Sossey-Alaoui K; Schiemann WP
    Neoplasia; 2015 Mar; 17(3):317-28. PubMed ID: 25810016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.